Literature DB >> 30988344

Helicobacter pylori infection, atrophic gastritis, and risk of pancreatic cancer: A population-based cohort study in a large Japanese population: the JPHC Study.

Mayo Hirabayashi1, Manami Inoue2, Norie Sawada3, Eiko Saito1,4, Sarah K Abe3, Akihisa Hidaka3, Motoki Iwasaki3, Taiki Yamaji3, Taichi Shimazu3, Shoichiro Tsugane3.   

Abstract

Helicobacter pylori (H. pylori), an established risk factor for gastric cancer, is suggested to also play a role in the development of pancreatic cancer; however, the association remains inconclusive. We examined this association among Japanese men and women. H. pylori and atrophic gastritis (AG) status were determined serologically, using blood sample collected during health checkups. A total of 20,116 subjects enrolled in the Japan Public Health Center-based Prospective Study Cohort II with available data on H. pylori seropositivity (anti-H. pylori) and AG were followed until the end of 2010. Cox proportional hazards models were used to calculate the hazard ratios (HR) and 95% confidence intervals (CI), using the information from the baseline survey. During 320,470 person-years of follow-up, 119 cases of pancreatic cancer were identified. No statically significant increase or decrease in pancreatic cancer risk was observed for H. pylori and AG status, independently or in combination. In a multivariable-adjusted model, we observed a non-significant decrease in the risk among those who had AG but were anti-H. pylori seronegative (HR 0.57, 95% CI 0.31-1.03). In a stratified analysis, we observed a statistically significant increased risk of pancreatic cancer for AG+ (HR 3.64, 95% CI 1.37-9.66), and AG+/anti-H. pylori- or AG+/anti-H. pylori+ (HR 5.21, 95% CI 1.14-23.87) among current smokers. Non-smokers in all categories of AG and anti-H. pylori showed a non-statistical decrease in the risk. There was no statistically significant interaction between H. pylori infection, AG status, and smoking status. Our findings suggest H. pylori seropositivity and AG, individually or in combination, are not associated with the risk of pancreatic cancer in a general Japanese population. Among current smokers, pancreatic cancer risk increased with AG, regardless of H. pylori infection status.

Entities:  

Mesh:

Year:  2019        PMID: 30988344      PMCID: PMC6465350          DOI: 10.1038/s41598-019-42365-w

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  53 in total

Review 1.  Risk factors for pancreatic cancer: a summary review of meta-analytical studies.

Authors:  Patrick Maisonneuve; Albert B Lowenfels
Journal:  Int J Epidemiol       Date:  2014-12-14       Impact factor: 7.196

2.  ABO blood group, Helicobacter pylori seropositivity, and risk of pancreatic cancer: a case-control study.

Authors:  Harvey A Risch; Herbert Yu; Lingeng Lu; Mark S Kidd
Journal:  J Natl Cancer Inst       Date:  2010-02-24       Impact factor: 13.506

3.  Prescreening of a high-risk group for gastric cancer by serologically determined Helicobacter pylori infection and atrophic gastritis.

Authors:  Shigeto Mizuno; Ikuya Miki; Tsukasa Ishida; Masaru Yoshida; Mitsuko Onoyama; Takeshi Azuma; Yasuki Habu; Hideto Inokuchi; Kotaro Ozasa; Kazumasa Miki; Yoshiyuki Watanabe
Journal:  Dig Dis Sci       Date:  2010-03-04       Impact factor: 3.199

4.  Positive serum antibody and negative tissue staining for Helicobacter pylori in subjects with atrophic body gastritis.

Authors:  W E Karnes; I M Samloff; M Siurala; M Kekki; P Sipponen; S W Kim; J H Walsh
Journal:  Gastroenterology       Date:  1991-07       Impact factor: 22.682

5.  Helicobacter pylori serology testing is a useful diagnostic screening tool for symptomatic inner city children.

Authors:  Priya Raj; John F Thompson; Debra H Pan
Journal:  Acta Paediatr       Date:  2017-01-20       Impact factor: 2.299

Review 6.  Gut hormones and appetite control.

Authors:  A M Wren; S R Bloom
Journal:  Gastroenterology       Date:  2007-05       Impact factor: 22.682

7.  Identification of gastrin as a growth peptide in human pancreatic cancer.

Authors:  J P Smith; A P Fantaskey; G Liu; I S Zagon
Journal:  Am J Physiol       Date:  1995-01

8.  Association between Helicobacter pylori and pancreatic cancer risk: a meta-analysis.

Authors:  Annaka Schulte; Nirmala Pandeya; Jonathan Fawcett; Lin Fritschi; Harvey A Risch; Penelope M Webb; David C Whiteman; Rachel E Neale
Journal:  Cancer Causes Control       Date:  2015-05-08       Impact factor: 2.506

9.  Expression and clinical significance of pepsinogen C in resectable pancreatic cancer.

Authors:  N Truan; F Vizoso; M F Fresno; R Fernández; I Quintela; E Alexandre; A Martínez
Journal:  Int J Biol Markers       Date:  2001 Jan-Mar       Impact factor: 3.248

10.  A prospective study of Helicobacter pylori in relation to the risk for pancreatic cancer.

Authors:  Björn Lindkvist; Dorthe Johansen; Anders Borgström; Jonas Manjer
Journal:  BMC Cancer       Date:  2008-11-05       Impact factor: 4.430

View more
  3 in total

Review 1.  The impact of the human microbiome in tumorigenesis, cancer progression, and biotherapeutic development.

Authors:  Claire M Doocey; Karen Finn; Craig Murphy; Caitriona M Guinane
Journal:  BMC Microbiol       Date:  2022-02-12       Impact factor: 3.605

2.  The relationship between Helicobacter pylori and pancreatic cancer: a meta-analysis.

Authors:  Wei Xu; Xiaochong Zhou; Minyue Yin; Jingwen Gao; Zhen Weng; Chunfang Xu
Journal:  Transl Cancer Res       Date:  2022-08       Impact factor: 0.496

Review 3.  Association Between Helicobacter pylori Infection and the Risk of Pancreatic Cancer: A Systematic Review Based on Observational Studies.

Authors:  Venkatesh Panthangi; Adrienne R Cyril Kurupp; Anjumol Raju; Gaurav Luthra; Mahrukh Shahbaz; Halah Almatooq; Paul Foucambert; Faith D Esbrand; Sana Zafar; Safeera Khan
Journal:  Cureus       Date:  2022-08-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.